Latest Breaking News On - Early feasibility study - Page 2 : comparemela.com

CARMAT Continues to Build on Its Momentum in the EFICAS Study and Reiterates Confidence in Its 2024 Outlook

EFICAS study reaches the milestone of 20 implants Interim study results above expectations Confirmation of short-term financial support from several key shareholders .

France generalUnited statesBois darcyGeorges pompidouEuropean unionFood drug administrationRegulatory newsChief executive officerFrench medtechEarly feasibility studyEuronext growthDes marchDrug administrationHospices civils de lyon

CARMAT: Availability of the 2023 Universal Registration Document

CARMAT: Availability of the 2023 Universal Registration Document
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalBois darcyUnited statesExperte carsten storkDusan oresanskyZwei rohstoff chancenCaroline carmagnolFood drug administrationFrench financial markets authority autoritEuropean unionRegulatory newsDes marchInvestors documentationFrench medtechEarly feasibility studyEuronext growth

Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study

SAN RAMON, Calif., April 10, 2024 (GLOBE NEWSWIRE) Raydiant Oximetry, Inc., a clinical-stage medical device company that develops medical tec.

United statesEastern virginia medical schoolElizabeth cherotNeilp rayRaydiant lumerahGeorge saadeInnovation fundDrug administrationRaydiant oximetry incNational institutes of healthDean for women healthUnited states foodInvestigational device exemptionEarly feasibility studyRaydiant oximetryDevice designation

CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024

CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalBois darcyCzech republicDennis riedlDusan oresanskyCaroline carmagnolEuropean unionFood drug administrationFrench financial markets authority autoritMidcap forumEuropean association of cardiothoracicInternational society for mechanical circulatory supportRegulatory newsInternational societyLung transplantation

Anteris Technologies continues to exceed market leader values with updated 30-day DurAVR™ THV Clinical Data

Anteris Technologies continues to exceed market leader values with updated 30-day DurAVR™ THV Clinical Data
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Anteris technologies ltdFirst in human studyEarly feasibility study